187 related articles for article (PubMed ID: 29151181)
1. Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region.
Hua R; Jiang X; Qi L; Guan S; Kuai Z; Qiao Y; Xu Y; Gong X; Shi Y; Kong W; Niu J; Zhang H; Shan Y
Immunol Res; 2018 Feb; 66(1):67-73. PubMed ID: 29151181
[TBL] [Abstract][Full Text] [Related]
2. Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
Logan M; Law J; Wong JAJ; Hockman D; Landi A; Chen C; Crawford K; Kundu J; Baldwin L; Johnson J; Dahiya A; LaChance G; Marcotrigiano J; Law M; Foung S; Tyrrell L; Houghton M
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795422
[TBL] [Abstract][Full Text] [Related]
3. Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus.
Ahsan A; Dar S; Hassan F; Ghafoor F; Yousuf MH; Shahzad-Ul-Hussan S
PLoS One; 2021; 16(8):e0256816. PubMed ID: 34449828
[TBL] [Abstract][Full Text] [Related]
4. Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.
Grollo L; Torresi J; Drummer H; Zeng W; Williamson N; Jackson DC
Antivir Ther; 2006; 11(8):1005-14. PubMed ID: 17302370
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.
Keck ZY; Xia J; Wang Y; Wang W; Krey T; Prentoe J; Carlsen T; Li AY; Patel AH; Lemon SM; Bukh J; Rey FA; Foung SK
PLoS Pathog; 2012; 8(4):e1002653. PubMed ID: 22511875
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2.
El Abd YS; Tabll AA; El Din NG; Hosny Ael-D; Moustafa RI; El-Shenawy R; Atef K; El-Awady MK
Virol J; 2011 Aug; 8():391. PubMed ID: 21819575
[TBL] [Abstract][Full Text] [Related]
7. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.
Giang E; Dorner M; Prentoe JC; Dreux M; Evans MJ; Bukh J; Rice CM; Ploss A; Burton DR; Law M
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6205-10. PubMed ID: 22492964
[TBL] [Abstract][Full Text] [Related]
8. Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design.
Keck ZY; Pierce BG; Lau P; Lu J; Wang Y; Underwood A; Bull RA; Prentoe J; Velázquez-Moctezuma R; Walker MR; Luciani F; Guest JD; Fauvelle C; Baumert TF; Bukh J; Lloyd AR; Foung SKH
PLoS Pathog; 2019 May; 15(5):e1007772. PubMed ID: 31100098
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope.
Pierce BG; Boucher EN; Piepenbrink KH; Ejemel M; Rapp CA; Thomas WD; Sundberg EJ; Weng Z; Wang Y
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794021
[TBL] [Abstract][Full Text] [Related]
10. Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies.
Tarr AW; Backx M; Hamed MR; Urbanowicz RA; McClure CP; Brown RJP; Ball JK
Antiviral Res; 2018 Dec; 160():25-37. PubMed ID: 30217650
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes.
Hadlock KG; Lanford RE; Perkins S; Rowe J; Yang Q; Levy S; Pileri P; Abrignani S; Foung SK
J Virol; 2000 Nov; 74(22):10407-16. PubMed ID: 11044085
[TBL] [Abstract][Full Text] [Related]
12. Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.
Christiansen D; Earnest-Silveira L; Chua B; Meuleman P; Boo I; Grubor-Bauk B; Jackson DC; Keck ZY; Foung SKH; Drummer HE; Gowans EJ; Torresi J
Sci Rep; 2018 Apr; 8(1):6483. PubMed ID: 29691437
[TBL] [Abstract][Full Text] [Related]
13. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
[TBL] [Abstract][Full Text] [Related]
14. Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding.
He L; Cheng Y; Kong L; Azadnia P; Giang E; Kim J; Wood MR; Wilson IA; Law M; Zhu J
Sci Rep; 2015 Aug; 5():12501. PubMed ID: 26238798
[TBL] [Abstract][Full Text] [Related]
15. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
Bose M; Mullick R; Das S; Das S; Karande AA
Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
[TBL] [Abstract][Full Text] [Related]
16. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
17. Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
Deng K; Liu R; Rao H; Jiang D; Wang J; Xie X; Wei L
PLoS One; 2015; 10(9):e0138756. PubMed ID: 26406225
[TBL] [Abstract][Full Text] [Related]
18. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
[TBL] [Abstract][Full Text] [Related]
19. Construction and characterization of an HCV-derived multi-epitope peptide antigen containing B-cell HVR1 mimotopes and T-cell conserved epitopes.
Gao J; Gong Y; Zhao P; Zhu Q; Yang X; Qi Z
Sci China C Life Sci; 2006 Oct; 49(5):490-9. PubMed ID: 17172057
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance.
Zhang C; Hua R; Cui Y; Wang S; Yan H; Li D; Zhang Y; Tu Z; Hao P; Chen X; Zhong J; Niu J; Jin X
PLoS One; 2017; 12(2):e0171217. PubMed ID: 28170421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]